Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Isabelle Viard is active.

Publication


Featured researches published by Isabelle Viard.


Science | 1998

Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin

Isabelle Viard; Philippe Wehrli; Roberto R. Bullani; Pascal Schneider; Nils Holler; Denis Salomon; Thomas Hunziker; Jean-Hilaire Saurat; Jürg Tschopp; Lars E. French


Archives of Dermatology | 2003

Treatment of Toxic Epidermal Necrolysis With High-Dose Intravenous Immunoglobulins: Multicenter Retrospective Analysis of 48 Consecutive Cases

Christa Prins; Francisco A. Kerdel; R. Steven Padilla; Thomas Hunziker; Sergio Chimenti; Isabelle Viard; Davide Mauri; Kirsten Flynn; Jennifer T. Trent; David J. Margolis; Jean-Hilaire Saurat; Lars E. French


Journal of Investigative Dermatology | 1999

Clusterin Gene Expression Mediates Resistance to Apoptotic Cell Death Induced by Heat Shock and Oxidative Stress

Isabelle Viard; Philippe Wehrli; Lan Jornot; Roberto Bullani; Jean-Luc Vechietti; Lars E. French; Jürg A. Schifferli; Jürg Tschopp


Journal of Investigative Dermatology | 2000

Death Receptors in Cutaneous Biology and Disease

Philippe Wehrli; Isabelle Viard; Roberto Bullani; Lars E. French; Jürg Tschopp


Archive | 1999

Verwendung einer Zusammensetzung zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen mit erhöhten extrazellulären FasL-Titern, Verfahren zur prophylaktischen Eignungs- bzw. Qualitätskontrolle derselben, Verfahren zur Herstellung von Arzneimitteln zur Behandlung obiger Krankheiten mit gesteigerter Wirksamkeit

Lars E. French; Isabelle Viard; Juerg Tschopp


Archive | 2004

Methods and compositions for treating diseases associated with increased Fas-ligand titers

Lars E. French; Isabelle Viard; Jurg Tschopp


Archive | 2000

Production and use of a composition containing ivig for treating diseases that are characterized by elevated extracellular fasl titers

E. Lars French; Isabelle Viard; Jurg Tschopp


Archive | 1999

Use of a composition for the manufacture of a medicament for the treatment of diseases with increased extracellular FasL titers method for the prophylactic or suitability quality control thereof, a process for the preparation of medicaments for the treatment of the above diseases with enhanced efficacy

Lars E. French; Isabelle Viard; Juerg Tschopp


Journal of Dermatological Science | 1998

Cellular flip (flice-inhibitory protein), a specific inhibitor of receptor-mediated cell death, is upregulated during cutaneous melanoma development

Roberto Bullani; Philippe Wehrli; Isabelle Viard; Jürg Tschopp; Jean-Hilaire Saurat; Lars E. French


Journal of Dermatological Science | 1998

Increased circulating soluble Fas ligand as a consequence of increased Fas ligand expression in patients with toxic epidermal necrolysis

Isabelle Viard; Thomas Hunziker; Jean-Hilaire Saurat; Lars E. French

Collaboration


Dive into the Isabelle Viard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jurg Tschopp

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David J. Margolis

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Davide Mauri

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge